Boerne, TX – July 2012 – Stanbio Laboratory will showcase its marquee ß-Hydroxybutyrate LiquiColor® enzymatic reagent system at booth 1631 during the American Association for Clinical Chemistry (AACC) Clinical Lab Expo. Stanbio Laboratory and its parent company, EKF Diagnostics, will also host a symposium entitled “The value, efficacy, and efficiency of ß-Hydroxybutyrate,” presented by renowned point-of-care expert Dr. James H. Nichols, Professor of Pathology at Tufts University School of Medicine, Boston, and Medical Director of Clinical Chemistry for Baystate Health in Springfield, Massachusetts.
“We’ve got an incredible story to share at this year’s Clinical Lab Expo,” said William R. Pippin, President of Stanbio Laboratory. “Our ß-Hydroxybutyrate LiquiColor® reagent system is quickly becoming the gold standard in testing for diabetic ketoacidosis. We’re very proud to have Dr. James H. Nichols presenting case studies to demonstrate the clinical efficacy of ß-Hydroxybutyrate LiquiColor® reagent system at this year’s expo,” Pippin added.
“Sales of the ß-Hydroxybutyrate LiquiColor® reagent system have exceeded our expectations,” said Gilbert A. Mejia, Stanbio Vice President of Sales and Marketing. “We’re finding the number of hospitals adding this assay has increased dramatically in just the past six months. We are extremely proud of the fact that so many of the most renowned and respected diabetes and endocrinology hospitals in the United States have chosen to use our reagent,” Mejia added.
Dr. Nichols will discuss the merits of the various methods of testing for diabetic ketoacidosis, including ß-Hydroxybutyrate. The free symposium will take place at 11:30 a.m. on Wednesday, July 18, at the Westin Bonaventure Hotel, Los Angeles (15 minutes’ walk from the LA Convention Center). Early reservation via firstname.lastname@example.org is recommended as seating is limited.
This year’s expo marks the first time Stanbio Laboratory and its parent company EKF Diagnostics will be exhibiting together at the American Association for Clinical Chemistry’s Annual Meeting and Clinical Lab Expo (AACC 2012).
Founded in 1960 and headquartered in Boerne, Texas, Stanbio Laboratory manufactures and markets medical testing and diagnostic devices including clinical chemistry, pregnancy, strep A, serology, urinalysis, and point-of-care hemoglobin tests. Stanbio Laboratory’s Quality System is ISO 13485 registered and its facility operates under USFDA current GMP requirements. Stanbio also offers OEM and private labeling capabilities and distributes products in over 125 countries worldwide. This year the company celebrates its 52nd year in business. To find out more about Stanbio, review its news, or learn more about its products, visit www.stanbio.com.
EKF Diagnostics Holdings plc is a worldwide manufacturer of near-patient care equipment for the measurement of glucose, lactate, hemoglobin, hematocrit and glycated hemoglobin (HbA1c). It offers its products to the professional clinical and research laboratories, doctors’ offices, sports clinics, and athletic testing sites. The company is headquartered in London, the United Kingdom.